The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Mark E. Linskey(University of California, Irvine), Steven N. Kalkanis(Henry Ford Health System), Douglas Kondziolka(Neurological Surgery), Minesh P. Mehta(Columbia University), Roy A. Patchell(Barrow Neurological Institute), Michael McDermott(Unknown), Jeffrey J. Olson(Emory University), David W. Andrews(Seoul National University), Tom Mikkelsen(Henry Ford Health System), Paula D. Robinson(McMaster University), Anthony L. Asher(Levine Cancer Institute), Laurie E. Gaspar(University of Colorado Cancer Center), Timothy C. Ryken, Jay S. Loeffler(Brigham and Women's Hospital), Nina A. Paleologos(NorthShore University HealthSystem), Mario Ammirati(The Ohio State University Wexner Medical Center), Stuart H. Burri(Levine Cancer Institute), Charles Cobbs(University of California, San Francisco)
Cited by 514
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
BCL-2 family proteins: changing partners in the dance towards death
|Cell Death and Differentiation|2017|1.6k